Literature DB >> 12458965

The functioning neuronal transporter for dopamine: kinetic mechanisms and effects of amphetamines, cocaine and methylphenidate.

James O Schenk1.   

Abstract

The dopamine transporter (DAT) is a transmembrane spanning protein that catalyzes the transport of dopamine across the neuronal membrane to concentrate the neurotransmitter inside the cell. Although the uptake of dopamine has been studied since the 1960s, more recent advances in knowledge of the protein itself and in making kinetically resolved measurements of its action have led to more insights into its mechanism and pharmacology. The literature of the kinetics of transporters and kinetic measurements of DAT activity is reviewed to provide an overview of the multisubstrate mechanism of DAT activity, its pharmacology with regard to amphetamine, cocaine and methylphenidate, and correlations of DAT activity with some behavioral outputs.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12458965     DOI: 10.1007/978-3-0348-8171-5_4

Source DB:  PubMed          Journal:  Prog Drug Res        ISSN: 0071-786X


  15 in total

1.  Methylphenidate exerts no neurotoxic, but neuroprotective effects in vitro.

Authors:  A G Ludolph; U Schaz; A Storch; S Liebau; J M Fegert; T M Boeckers
Journal:  J Neural Transm (Vienna)       Date:  2006-06-01       Impact factor: 3.575

Review 2.  Novel approaches to the treatment of cocaine addiction.

Authors:  Mehmet Sofuoglu; Thomas R Kosten
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 3.  Exploring the Validity of Proposed Transgenic Animal Models of Attention-Deficit Hyperactivity Disorder (ADHD).

Authors:  June Bryan de la Peña; Irene Joy Dela Peña; Raly James Custodio; Chrislean Jun Botanas; Hee Jin Kim; Jae Hoon Cheong
Journal:  Mol Neurobiol       Date:  2017-05-22       Impact factor: 5.590

4.  Nonclassical, distinct endocytic signals dictate constitutive and PKC-regulated neurotransmitter transporter internalization.

Authors:  Katherine L Holton; Merewyn K Loder; Haley E Melikian
Journal:  Nat Neurosci       Date:  2005-07       Impact factor: 24.884

5.  Treatment of disorders of hypersomnolence.

Authors:  Olufemi Adenuga; Hrayr Attarian
Journal:  Curr Treat Options Neurol       Date:  2014-09       Impact factor: 3.598

6.  Substrate binding and formation of an occluded state in the leucine transporter.

Authors:  Leyla Celik; Birgit Schiøtt; Emad Tajkhorshid
Journal:  Biophys J       Date:  2007-11-16       Impact factor: 4.033

7.  Time-of-day differences in dopamine clearance in the rat medial prefrontal cortex and nucleus accumbens.

Authors:  Evan P Sleipness; Heiko T Jansen; James O Schenk; Barbara A Sorg
Journal:  Synapse       Date:  2008-12       Impact factor: 2.562

8.  Cocaine alters vesicular dopamine sequestration and potassium-stimulated dopamine release: the role of D2 receptor activation.

Authors:  Sarah J Farnsworth; Trent J Volz; Glen R Hanson; Annette E Fleckenstein
Journal:  J Pharmacol Exp Ther       Date:  2008-11-26       Impact factor: 4.030

Review 9.  Unfaithful neurotransmitter transporters: focus on serotonin uptake and implications for antidepressant efficacy.

Authors:  Lynette C Daws
Journal:  Pharmacol Ther       Date:  2008-10-29       Impact factor: 12.310

10.  Neuropharmacological mechanisms underlying the neuroprotective effects of methylphenidate.

Authors:  T J Volz
Journal:  Curr Neuropharmacol       Date:  2008-12       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.